Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. - Wikidata - awgldk - TriplyDB

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q46464366

about

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology Vascular Ageing and Exercise: Focus on Cellular Reparative Processes Vascular repair strategies in type 2 diabetes: novel insights Redox regulation of stem/progenitor cells and bone marrow niche The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection Endothelial cells derived from nuclear reprogramming Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study.Diabetes-associated macrovascular complications: cell-based therapy a new tool?Assessment of endothelial dysfunction in childhood obesity and clinical use.Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress.Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study.Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1.Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells.Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae?Substance P accelerates wound healing in type 2 diabetic mice through endothelial progenitor cell mobilization and Yes-associated protein activation Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia.Endothelial progenitor cells: therapeutic perspective for ischemic stroke.Image-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe.Glucose challenge increases circulating progenitor cells in Asian Indian male subjects with normal glucose tolerance which is compromised in subjects with pre-diabetes: A pilot study.Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum.Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent Effects of lycopene on number and function of human peripheral blood endothelial progenitor cells cultivated with high glucose Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.Stepwise optimization of the procedure for assessment of circulating progenitor cells in patients with myocardial infarction.Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose.Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities.Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice.

P2860

Q26744760-14E04B4E-3408-484E-ACFE-4C54E9B3835A Q26772296-3CCBE744-CC3D-4929-96D5-CA04666FD518 Q26778658-0E3B14CB-9EBB-43ED-815F-1AF209405BF9 Q26851313-34F2A255-694A-4E30-9EDE-440E98D2772C Q26852080-36741A3E-48D8-420B-B22C-D4586E804527 Q27001633-DE7FF561-2FD7-4110-AFF4-9C78306D7280 Q27002524-6D9DAC44-96A5-4A64-A719-635F038AD5C7 Q27011819-87565A22-0123-4F6B-8D7D-CBD7BFA01EB1 Q27011837-023529A2-5C5C-483A-806F-F4D8D563DD5E Q27026834-7DD90076-0744-4E3E-9868-22A7EB8CB7EC Q27312663-B2AE39FF-70E4-4581-9842-DCF8991F014B Q30409726-9275299A-94C0-45AB-999B-2B2CC34612CF Q30428895-94DA751D-0DE2-495E-B09B-82534AB21065 Q30430798-41D5C834-446B-4BD2-85F6-F7A048291F23 Q30433579-04B5DF0C-2813-4BC9-9FFF-23B6DF00A765 Q30459188-88909A52-736E-4A88-81A2-04A882C940C5 Q30495462-41174ADA-00A5-4206-BE66-89AECB24BB1C Q33396460-2EC75AA7-5375-4147-8857-86891452E715 Q33399716-4A7EA3F6-5671-4056-A0B6-43A4C810615D Q33410261-91754FB9-0CAE-4483-AD37-1375A8B100D4 Q33550596-B4F1FFEE-7293-4F46-BA62-0368D8B23C1A Q33602535-B9A70D6B-5D51-4C1E-8C22-BEF427D21574 Q33674663-0AEF1EAA-48FE-43D4-AEF0-C99B574CB1DD Q33698023-486BDFD5-2A3A-4D70-BBFD-60C380CE98D4 Q33705402-988C3E19-8CE4-4DA1-B222-948B75D13FB1 Q33779819-6277620C-7128-40AC-9AE5-5B438C3B8BA7 Q33789628-4DA9E137-88FD-4E12-81A7-E455ECA2EA44 Q33804692-78E23A02-AE81-43FB-9F33-12E7BB34FE2C Q33822512-544AD5FD-C8BD-4A61-9746-21C8BA4BD0BE Q33847880-1786F705-444B-48DC-A3C7-A2C3BCDCC03E Q33929661-B302BDD9-C082-4BAE-B4F4-3FB153662661 Q33932817-4758FDA2-19E3-43F7-96E2-5F93E5386347 Q33960253-8055EC9F-52B9-4765-9B5D-E3920A98023A Q33995043-CCADCEAB-4354-4BA5-AF68-702976E8F20C Q34006386-C5363C23-4288-4CF1-A390-8DAB10EE5415 Q34024355-99F8A1FF-D561-44DC-BEAA-AC5C726D04F3 Q34137714-D62FE882-AFB8-4D5D-822A-9AFFA6782A4B Q34305712-E0A8F323-9934-4211-B90B-C93DF7A315C3 Q34345679-A13C3106-6F8F-44F5-AF74-B36E58EE08A8 Q34360080-5BABDD66-4E0D-4275-9FE7-68D2996EF3B9

P2860

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q46464366

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Circulating endothelial progen ...... s of type 2 diabetes mellitus.

@en

Circulating endothelial progen ...... s of type 2 diabetes mellitus.

@nl

type

label

Circulating endothelial progen ...... s of type 2 diabetes mellitus.

@en

Circulating endothelial progen ...... s of type 2 diabetes mellitus.

@nl

prefLabel

Circulating endothelial progen ...... s of type 2 diabetes mellitus.

@en

Circulating endothelial progen ...... s of type 2 diabetes mellitus.

@nl

P1433

Q46464366-C7BF3F1E-170D-435B-B32E-5651B5B37C4A

P1476

Q46464366-01E4E591-C9AF-40B9-8530-2216E602B16D

P2093

Q46464366-4BE425F5-98DA-4CEF-B0F9-3D9A87D20115

Q46464366-82490C81-6D25-445F-93C0-6E0B0DE475AA

Q46464366-83CD0071-B9D2-4A71-85A1-9D2214A642A4

Q46464366-8BCE9CE7-7AE0-491D-8B67-965EC9D799B8

Q46464366-8CAE4BE9-2DFE-4E98-A443-626A9C7FF6E7

Q46464366-9351C095-417D-4C00-A935-608CBEEB026E

Q46464366-B1997515-7F50-4F8E-B4C8-9C08FBFC078C

Q46464366-EE23C86B-013D-4C41-8CDC-1EE97CD0DE4E

Q46464366-FF9C711F-0400-4A31-9504-929CB671B700

P304

Q46464366-DF8C3307-7399-487D-B18D-F2D4A97B497D

P31

Q46464366-7DB43A60-974D-4021-A3EA-01AB6CDA16D4

P356

Q46464366-BDCD29BE-9D30-45CA-8111-5D38324E63F1

P407

Q46464366-E926704A-279A-48ED-9CF1-CE23D3CCA00C

P433

Q46464366-38EC04F2-6360-4DBD-BEB4-5D1DFF46DBE2

P478

Q46464366-5D397319-2E94-40E8-B170-E1DAB011F8F6

P50

Q46464366-0DA88649-73BD-49FA-9984-DA3D33914FD0

Q46464366-657F42FC-2E51-4ABA-8B8C-FB491461BC8E

P577

Q46464366-020C6403-6BEE-4510-9333-3643E39053BA

P5875

Q46464366-8671099C-6E57-40F1-9F7B-E4AFF466FC87

P698

Q46464366-41F4CD40-1B05-4C18-937A-164F0D0D74CA

P921

Q46464366-E7B21463-1318-440F-A2D1-945D06445E11

Q46464366-EE74F6DA-C22E-4073-9DA6-E53020CB1216

P356

J.JACC.2004.11.067

P1433

Journal of the American College of Cardiology

P1476

Circulating endothelial progen ...... ns of type 2 diabetes mellitus

@en

P2093

Angelo Avogaro

http://www.w3.org/2001/XMLSchema#string

Antonio Tiengo

http://www.w3.org/2001/XMLSchema#string

Franco Grego

http://www.w3.org/2001/XMLSchema#string

Ilenia Baesso

http://www.w3.org/2001/XMLSchema#string

Marta Miorin

http://www.w3.org/2001/XMLSchema#string

Mirko Menegolo

http://www.w3.org/2001/XMLSchema#string

Monica Facco

http://www.w3.org/2001/XMLSchema#string

Saula Vigili de Kreutzenberg

http://www.w3.org/2001/XMLSchema#string

Sondra Bonamico

http://www.w3.org/2001/XMLSchema#string

P304

1449-1457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2004.11.067

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Gian Paolo Fadini

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7876684

http://www.w3.org/2001/XMLSchema#string

P698

15862417

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes